Novo Nordisks Ozempic 2.0 Mg Receives Us Fda Approval To Treat Type 2 Diabetes

Novo Nordisks Ozempic 2.0 Mg Receives Us Fda Approval To Treat Type 2 Diabetes

By, Admin 30 March 2022

Novo Nordisk, A Leading Global Healthcare Company, Announced That The Us Food And Drug Administration (Fda) Has Approved A 2.0 Mg Dose Of Ozempic (Once-Weekly Semaglutide Subcutaneous Injection), A Glucagon-Like Peptide-1 (Glp-1) Analogue For The Treatment Of Adults With Type 2 Diabetes. Ozempic Is Now Approved In The Us At 0.5 Mg,1.0 Mg And 2.0 Mg Doses For The Treatment Of Type 2 Diabetes In Adults. Further, Ozempic Is Indicated To Reduce The Risk Of Major Cardiovascular Events Such As Heart Attack, Stroke Or Death In Adults With Type 2 Diabetes And Known Heart Disease.The Fda Approval Is Based On The Results From The Sustain Forte Trial. In The Trial, People Treated With Semaglutide 2.0 Mg Achieved A Statistically Significant And Superior Reduction In Hba1C At Week 40 Compared To Semaglutide 1.0 Mg. In The Trial, Both Doses Of Semaglutide Appeared To Have A Safe And Well-Tolerated Profile. The Most Common Adverse Events Were Gastrointestinal. Compared To Semaglutide 1.0 Mg, The Gastrointestinal Adverse Events Were Similar For Semaglutide 2.0 Mg.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!